ArticleNanomaterials (Basel, Switzerland)2026
Design and Application of Fluorescence Probes for Gold Nanocage Complex Perovskite Quantum Dots.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application Advances of Gold Nanoparticles in Cancer Theranostics: From Physicochemical Mechanisms to Multifunctional Nanoplatforms.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a gold nanocage composite perovskite quantum dot fluorescent probe (MB-GNCs-PQDs) was designed and constructed. The GNCs-PQDs composite system was formed by the combination of gold nanocages (GNCs) and perovskite quantum dots (PQDs). Spectral analysis confirmed that its fluorescence intensity was significantly enhanced by 15.38% compared with that of pure PQDs. Furthermore, amino modification was performed on the nanomaterial. Through the specific design of molecular beacons (MB), the fluorescence emission spectrum of the probe was matched with the absorption peak of the quencher group BHQ2, and the effective closure of the fluorescence signal was achieved based on the Fluorescence Resonance Energy Transfer (FRET) effect. Subsequently, MB was immobilized on the surface of the composite system via amino covalent conjugation to complete the probe preparation. The prepared probe was applied to the detection of miRNA-4529-3P and miR-301b-3p, which are tumor markers of non-small cell lung cancer (NSCLC). The hybridization of target molecules with MB could trigger the disruption of FRET and the recovery of fluorescence signal, exhibiting excellent recognition performance. This study provides an experimental basis for the preparation of composite fluorescent probes, and the developed probe has potential application value in the field of tumor marker detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.